Article information
Full text is only aviable in PDF
BIBLIOGRAFA
[1.]
G.T. Ferguson.
Rastreio e Intervcnção Precoce na DPCO. Hospital Practice.
EdiçãO Portuguesa, vol. 3 (1999), pp. 23-35
[2.]
A.S. Buist.
Definition, Epidemiology and Natural History of COPD.
[3.]
F. Rodrigues, J. Cardoso, DPOC.
25 Perguntas Frequentes em Pneumologia, Permanyer Portugal, (1998),
[4.]
A.S. Buist.
The Economic Burden of COPD.
ERS Annual Meeting,
[5.]
R. Pawels.
General Introduction to GOLD Guidelines,
[6.]
The COPD guidelines Group of the Stan Dards of Care Committee of the BTS.
BTS Guidelines for the Management of Chronic Obstruclive Pulmonary Disease.
Thorax, 52 (1997), pp. S4-S6
[7.]
S. Hurd.
Objectives of GOLD,
[8.]
B. Rijcken, J. Britton.
Epidemiology of Chronic Obstructive Pulmonary Disease.
European Respiratory Mon, 7 (1998), pp. 41-73
[9.]
D.S. Postma, P. Vermeire.
The Natural History of Chronic Obstructive Pulmonary Disease.
European Respiratory Mon, 7 (1998), pp. 74-83
[10.]
C. Fletcher, R. Peto.
The Natural History of Chronic Airflow Obstruction.
Br Med J, 1 (1977), pp. 1645-1648
[11.]
A.G.N. Agustí.
The Science of Symptoms in Chronic Pulmonary Disease.
Eur Respir Rev, 9 (1999), pp. 160-164
[12.]
T. Clark.
Diagnosis and Follow-up of COPD,
[13.]
N.R. Anthonisen, E.C. Wright, J.E. Hodgkin, IPPB Trial Group.
Prognosis in Chronic Obstructive Pulmonary Disease.
Am Rev Respir Dis, 133 (1986), pp. 14-20
[14.]
N.M. Siafakas, P. Vermeire, N.B. Pride, et al.
Optimal Assessment and Management of Chronic Obstructive Pulmonary Disease (COPD). A Consensus Statement of the European Respiratory Society (ERS).
Eur Respir J, 8 (1995), pp. 1398-1420
[15.]
P.S. Burge.
EUROSCOP ISOLDE and The Copenhagen City Lung Study.
Thorax, 54 (1999), pp. 287-288
[16.]
R. Pauwels.
Preliminary GOLD Recommendations for the Management of COPD.
[17.]
N.R. Anthonisen, J.E. Connett, J.P. Kiley, et al.
Lung Health Study Research Group. Effects of Smoking Inter-vention and the Use of an Inhaled Anticholinergic Bronchodilator on the Rate of Decline of FEV1.
JAMA, 272 (1994), pp. 1497-1505
[18.]
R.A. Pauwels, C.G. Löfdahl, L.A. Laitinen, ERS Study on Chronlc Obstructive Pulmonary Disease, et al.
Long-Term Treatment with Inhaled Budesonidc in Persons with Mild Chronic Obstructive Pulmonary Disease who Continue Smoking.
N Engl J Med, 340 (1999), pp. 1948-1953
[19.]
D.E. Njewoehner, M.L. Erbland, R.H. Deupree, Department of Veterans Affairs Cooperative Study Group, et al.
Effect of Systemic Glucoconicoids on Exacerbations of Chronic Obstructive Pulmonary Disease.
N Engl J Med, 340 (1999), pp. 1941-1947
[20.]
C. Jenkins.
Pulmonary Rehabilitation and Education in COPD,
[21.]
B.D. Mink.
O Exercício e a Doenya Pulmonar Obstrutiva Crónica. Pequenos Ganhos Físicos Revertem em. Grandcs Dividendos.
The Physician and Sponsrncdicine, 1 (1999), pp. 23-30
[22.]
S. Sullivan.
Socioeconomic Aspects of COPD,
[23.]
D.E. Comissão, S.P.P. Trabalho Da.
Norm as Clínicas para lntervcnção na Doença Pulmonar Obstrutiva Crónica.
Rev Pon Pneumol III, 3 (1998), pp. 331-362
[24.]
M.C. Gomes, T. Serra.
Oxigcnotcrapia Domiciliária de Longa Duração.
HPV, 3 (1996), pp. 109-113
Copyright © 2000. Sociedade Portuguesa de Pneumologia/SPP
Special content about COVID-19
- Assisted mobilisation in critical patients with COVID-19
- Two years of COVID-19: Trends in rehabilitation
- Comparison of different field tests to assess the physical capacity of post-COVID-19 patients
- New insights in circulating peptidome to differentiate mild to severe COVID-19 patients: Preliminary report
Recommended
articles
articles
10.1016/j.pulmoe.2023.09.005
Pulmonol. 2020;26:95-100
Pulmonol. 2019;25:334-9
Open access
This work is licensed under a Creative Commons Attribution 4.0 International License.
Publish in
Pulmonology
Pulmonology
- Home
- All contents
- Publish your article
- About the journal
- Metrics
- Open access
Article options